StonvexLoading…
StonvexStonvexStonvexCore line items from OSCR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $28.59M | $20.58M | $21.35M | $64.93M |
Operating Income | $-396.36M | $57.27M | $-235.62M | $-589.87M |
Net Income | $-443.15M | $25.43M | $-270.73M | $-606.27M |
EPS (Diluted) | $-1.69 | $0.10 | $-1.22 | $-2.85 |
Total Assets | $6.33B | $4.84B | $3.60B | $4.53B |
Total Liabilities | $5.34B | $3.82B | $2.80B | $3.63B |
Cash & Equivalents | $2.77B | $1.53B | $1.87B | $1.56B |
Free Cash Flow OCF − CapEx | $1.06B | $950.30M | $-297.74M | $351.34M |
Shares Outstanding | 262.39M | 265.85M | 221.66M | 212.47M |